AlphaCentric Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-49,500
| Closed | -$1.11M | – | 239 |
|
|
2023
Q3 | $1.11M | Hold |
49,500
| – | – | 0.63% | 55 |
|
|
2023
Q2 | $1.06M | Hold |
49,500
| – | – | 0.59% | 66 |
|
|
2023
Q1 | $1.19M | Hold |
49,500
| – | – | 0.82% | 36 |
|
|
2022
Q4 | $1.15M | Sell |
49,500
-19,000
| -28% | -$441K | 1.13% | 26 |
|
|
2022
Q3 | $1.1M | Buy |
+68,500
| New | +$1.1M | 1.13% | 21 |
|
|
2021
Q4 | $1.13M | Buy |
60,500
+23,500
| +64% | +$439K | 0.33% | 26 |
|
|
2021
Q3 | $730K | Buy |
37,000
+28,000
| +311% | +$552K | 0.19% | 51 |
|
|
2021
Q2 | $213K | Hold |
9,000
| – | – | 0.06% | 104 |
|
|
2021
Q1 | $213K | Hold |
9,000
| – | – | 0.07% | 92 |
|
|
2020
Q4 | $180K | Buy |
9,000
+6,600
| +275% | +$132K | 0.08% | 73 |
|
|
2020
Q3 | $50K | Sell |
2,400
-750
| -24% | -$15.6K | 0.02% | 106 |
|
|
2020
Q2 | $55K | Buy |
+3,150
| New | +$55K | 0.03% | 81 |
|